Mirabegron TCI M3567

Mirabegron, with CAS number 223673-61-8, is a chemical compound widely utilized in pharmaceutical research, particularly within the fields of health sciences and pharmacology. It serves as a key reagent in experimental studies aimed at understanding the physiological and pharmacological effects on the urinary system. This compound is specifically known for its ability to interact with muscarinic receptors, making it a valuable tool for studying the mechanisms of urinary tract function and dysfunction. Due to its relevance in drug development and clinical testing, Mirabegron is frequently used in laboratory settings to support research into therapeutic interventions for various health conditions.

Mirabegron is preferred in laboratory settings due to its chemical stability and compatibility with a wide range of experimental conditions. Its complex molecular structure allows for in-depth investigations into its interactions with proteins and enzymes, providing insights into its biological activity. Additionally, its resistance to degradation ensures consistent results over extended periods, making it suitable for long-term research projects. The compound’s reliability and reproducibility make it a trusted choice for scientists conducting experiments that require precise and repeatable outcomes.

In Indonesian laboratories, Mirabegron is commonly used in research related to urinary tract diseases, such as infections and kidney function disorders. It plays a crucial role in studies aimed at developing new therapeutic approaches for chronic conditions. Its application extends to pharmacological research, where it helps in evaluating the effects of drugs on the human body. As a result, Mirabegron remains an essential component in the pursuit of scientific advancements in the field of health sciences.

• Urinary Tract Disease Research: Mirabegron is used to study the pharmacological effects on the urinary system, aiding in the development of treatments for infections and kidney-related disorders.
• Drug Development and Testing: It serves as a key reagent in the formulation and testing of new pharmaceutical compounds, supporting preclinical and clinical research.
• Pharmacological Mechanism Studies: Mirabegron enables researchers to investigate interactions with muscarinic receptors, contributing to a better understanding of drug action mechanisms.
• Chronic Disease Therapeutic Research: It is employed in studies aimed at developing long-term therapies for conditions such as chronic kidney disease and urinary tract dysfunction.
• Experimental Toxicology: Mirabegron is used to assess the safety and toxicity profiles of new compounds, ensuring their suitability for human use.

Mirabegron should be stored in a cool, dry environment to maintain its chemical stability and prevent degradation. It is recommended to keep the compound in a sealed container to minimize exposure to moisture and air. Laboratory personnel should handle Mirabegron with care, using appropriate personal protective equipment such as gloves and safety goggles to ensure safety during handling. The compound should be stored away from incompatible substances to avoid any potential chemical reactions. Regular monitoring of storage conditions is essential to maintain the integrity of the material for long-term research use. Proper labeling of containers is also important to ensure safe handling and prevent accidental exposure.

—